evunzekibart (ATOR-1017) / Alligator Biosci 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evunzekibart (ATOR-1017) / Alligator Biosci
NCT04144842: Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017

Completed
1
27
Europe
ATOR-1017
Alligator Bioscience AB
Solid Tumor, Neoplasms
03/23
03/23

Download Options